Xu Steven Xu

19PUBLICATIONS
14CO-AUTHORS
Haematological tumoursAutoimmunityPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 07, 2026
Epcoritamab Step-Up Dosing Regimen Selection and Optimization Using Repeated Time-to-Event Modeling for Cytokine Release Syndrome Risk Mitigation.

|Jun 05, 2026
Translating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development Roadmap.

|May 15, 2026
Model-Informed Dosing Strategies for Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma.

|Mar 02, 2026
QT Prolongation Risk of Antibody-Drug Conjugates.

Xu Steven Xu, Kinjal Sanghavi, Summer Feng

|Feb 12, 2025
Optimal Dosing Regimen for Epcoritamab, a Subcutaneous Bispecific Antibody, in Relapsed or Refractory Large B-Cell Lymphoma.

Tommy Li, Leonid Gibiansky, Apurvasena Parikh

|Jan 08, 2025
Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapy.

Haolun Ding, Min Yuan, Yaning Yang

Pageof 4

Frequent Collaborators

4 joint publications

Min Yuan

3 joint publications

Tommy Li

2 joint publications

Jitendra Jonnagaddala

2 joint publications

Hong Zhang